SIMILAR PATTERNS OF AMINO ACIDS FOR 3EKT_B_017B200_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aye PROCARBOXYPEPTIDASE
A2


(Homo sapiens)
PF00246
(Peptidase_M14)
PF02244
(Propep_M14)
5 ALA A 290
VAL A  74
PRO A 282
ALA A 283
ILE A 286
None
1.05A 3ektB-1ayeA:
undetectable
3ektB-1ayeA:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bhy P64K

(Neisseria
meningitidis)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ALA A 555
GLY A 538
ILE A 527
ALA A 583
ILE A 565
None
0.85A 3ektB-1bhyA:
undetectable
3ektB-1bhyA:
13.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bu8 PROTEIN (PANCREATIC
LIPASE RELATED
PROTEIN 2)


(Rattus
norvegicus)
PF00151
(Lipase)
PF01477
(PLAT)
5 ALA A 161
VAL A 124
GLY A 150
ILE A 149
ILE A 128
None
1.01A 3ektB-1bu8A:
undetectable
3ektB-1bu8A:
14.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g67 THIAMIN PHOSPHATE
SYNTHASE


(Bacillus
subtilis)
PF02581
(TMP-TENI)
5 ASP A  94
GLY A 105
ILE A 126
ALA A 115
ILE A 108
None
1.06A 3ektB-1g67A:
undetectable
3ektB-1g67A:
17.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
1.20A 3ektB-1hvcA:
13.8
3ektB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-3.8A)
1.22A 3ektB-1hvcA:
13.8
3ektB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.63A 3ektB-1hvcA:
13.8
3ektB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.42A 3ektB-1hvcA:
13.8
3ektB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.95A 3ektB-1hvcA:
13.8
3ektB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
VAL A  32
GLY A  48
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 (-3.6A)
0.91A 3ektB-1hvcA:
13.8
3ektB-1hvcA:
46.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j3u ASPARTASE

(Bacillus sp.
YM55-1)
PF00206
(Lyase_1)
PF10415
(FumaraseC_C)
6 ALA A  57
VAL A 135
GLY A  50
ILE A  82
ALA A 115
ILE A  74
None
1.20A 3ektB-1j3uA:
undetectable
3ektB-1j3uA:
13.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j6u UDP-N-ACETYLMURAMATE
-ALANINE LIGASE MURC


(Thermotoga
maritima)
PF01225
(Mur_ligase)
PF02875
(Mur_ligase_C)
PF08245
(Mur_ligase_M)
5 ALA A 363
ASP A 323
GLY A 358
PRO A 347
ILE A 325
None
1.04A 3ektB-1j6uA:
undetectable
3ektB-1j6uA:
10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l8w VLSE1

(Borreliella
burgdorferi)
PF00921
(Lipoprotein_2)
5 ALA A 290
ASP A 160
ILE A 171
PRO A 255
ALA A 283
None
1.01A 3ektB-1l8wA:
undetectable
3ektB-1l8wA:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nlu SEDOLISIN

(Pseudomonas sp.)
no annotation 5 ALA A 289
GLY A 295
ILE A  88
PRO A  10
ALA A 272
None
1.09A 3ektB-1nluA:
undetectable
3ektB-1nluA:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q8f PYRIMIDINE
NUCLEOSIDE HYDROLASE


(Escherichia
coli)
PF01156
(IU_nuc_hydro)
6 ALA A  19
ASP A 240
VAL A 238
GLY A 245
ILE A 248
ILE A  18
None
GOL  A3001 ( 2.5A)
None
None
None
None
1.42A 3ektB-1q8fA:
undetectable
3ektB-1q8fA:
15.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
None
0.83A 3ektB-1q9pA:
10.3
3ektB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
None
0.52A 3ektB-1q9pA:
10.3
3ektB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
None
1.16A 3ektB-1sivA:
18.7
3ektB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.51A 3ektB-1sivA:
18.7
3ektB-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t3q QUINOLINE
2-OXIDOREDUCTASE
LARGE SUBUNIT


(Pseudomonas
putida)
PF01315
(Ald_Xan_dh_C)
PF02738
(Ald_Xan_dh_C2)
5 ALA B 515
VAL B 499
GLY B 553
ALA B 533
ILE B 531
None
1.05A 3ektB-1t3qB:
undetectable
3ektB-1t3qB:
8.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uz5 402AA LONG
HYPOTHETICAL
MOLYBDOPTERIN
BIOSYNTHESIS MOEA
PROTEIN


(Pyrococcus
horikoshii)
PF00994
(MoCF_biosynth)
PF03453
(MoeA_N)
PF03454
(MoeA_C)
5 ALA A  99
VAL A  83
GLY A 109
ALA A  54
ILE A 101
None
1.02A 3ektB-1uz5A:
undetectable
3ektB-1uz5A:
14.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.98A 3ektB-1v5fA:
undetectable
3ektB-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wyd HYPOTHETICAL
ASPARTYL-TRNA
SYNTHETASE


(Sulfurisphaera
tokodaii)
PF00152
(tRNA-synt_2)
PF01336
(tRNA_anti-codon)
5 VAL A 250
GLY A 410
ILE A 411
ALA A 140
ILE A 253
None
1.01A 3ektB-1wydA:
undetectable
3ektB-1wydA:
11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zaw 50S RIBOSOMAL
PROTEIN L10


(Thermotoga
maritima)
PF00466
(Ribosomal_L10)
5 ALA A  27
GLY A 116
ILE A  24
ALA A  95
ILE A  99
None
1.02A 3ektB-1zawA:
undetectable
3ektB-1zawA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ct8 METHIONYL-TRNA
SYNTHETASE


(Aquifex
aeolicus)
PF00133
(tRNA-synt_1)
PF08264
(Anticodon_1)
PF09334
(tRNA-synt_1g)
5 ASP A  52
GLY A 216
PRO A  69
ALA A  62
ILE A  58
MSP  A 501 (-3.9A)
None
None
None
None
1.08A 3ektB-2ct8A:
undetectable
3ektB-2ct8A:
13.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e0p ENDOGLUCANASE

(Ruminiclostridium
thermocellum)
PF12891
(Glyco_hydro_44)
5 GLY A 371
ILE A 372
PRO A 314
ALA A 313
ILE A 295
None
1.00A 3ektB-2e0pA:
undetectable
3ektB-2e0pA:
12.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.80A 3ektB-2fmbA:
15.2
3ektB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.40A 3ektB-2fmbA:
15.2
3ektB-2fmbA:
31.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2grj DEPHOSPHO-COA KINASE

(Thermotoga
maritima)
PF01121
(CoaE)
5 ALA A 126
GLY A   7
ILE A 148
ALA A 138
ILE A 131
None
1.05A 3ektB-2grjA:
undetectable
3ektB-2grjA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3e DIAMINOPIMELATE
DECARBOXYLASE


(Aquifex
aeolicus)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
5 ALA A 355
VAL A 371
GLY A 345
ILE A 308
ILE A 328
None
0.90A 3ektB-2p3eA:
undetectable
3ektB-2p3eA:
14.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q4f HISTIDINE-CONTAINING
PHOSPHOTRANSFER
PROTEIN 1


(Oryza sativa)
PF01627
(Hpt)
5 ASP A  76
VAL A  75
GLY A 112
ALA A  62
ILE A  61
None
1.01A 3ektB-2q4fA:
undetectable
3ektB-2q4fA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r44 UNCHARACTERIZED
PROTEIN


(Cytophaga
hutchinsonii)
PF07726
(AAA_3)
5 ASP A  72
GLY A 105
ILE A  88
ALA A 114
ILE A 112
None
0.93A 3ektB-2r44A:
undetectable
3ektB-2r44A:
14.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
GLY A  48
PRO A  81
ALA A  82
ILE A  84
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.6A)
AB1  A 501 ( 4.2A)
0.83A 3ektB-2rkfA:
20.8
3ektB-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
1.40A 3ektB-2rkfA:
20.8
3ektB-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ALA A  82
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.6A)
AB1  A 501 ( 4.2A)
0.35A 3ektB-2rkfA:
20.8
3ektB-2rkfA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wyo GLUTATHIONE
SYNTHETASE


(Trypanosoma
brucei)
PF03199
(GSH_synthase)
PF03917
(GSH_synth_ATP)
5 VAL A 320
GLY A 116
ILE A 503
ALA A 217
ILE A 350
None
1.03A 3ektB-2wyoA:
undetectable
3ektB-2wyoA:
8.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yjq CEL44C

(Paenibacillus
polymyxa)
PF12891
(Glyco_hydro_44)
5 GLY A 370
ILE A 371
PRO A 313
ALA A 312
ILE A 296
None
1.01A 3ektB-2yjqA:
undetectable
3ektB-2yjqA:
10.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c1a PUTATIVE
OXIDOREDUCTASE


(Magnetospirillum
magnetotacticum)
PF01408
(GFO_IDH_MocA)
5 ASP A 245
ALA A 248
ASP A 250
GLY A 266
ALA A 234
None
0.92A 3ektB-3c1aA:
undetectable
3ektB-3c1aA:
17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gzs UNCHARACTERIZED SUSD
SUPERFAMILY PROTEIN


(Bacteroides
fragilis)
PF12741
(SusD-like)
5 ASP A 419
GLY A 302
ILE A 305
PRO A 430
ALA A 429
None
0.88A 3ektB-3gzsA:
undetectable
3ektB-3gzsA:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ikf 2-C-METHYL-D-ERYTHRI
TOL
2,4-CYCLODIPHOSPHATE
SYNTHASE


(Burkholderia
pseudomallei)
PF02542
(YgbB)
5 VAL A 131
GLY A  24
ILE A  21
ALA A 150
ILE A 100
None
1.06A 3ektB-3ikfA:
undetectable
3ektB-3ikfA:
18.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3in1 UNCHARACTERIZED
SUGAR KINASE YDJH


(Escherichia
coli)
PF00294
(PfkB)
5 ALA A  12
VAL A  14
GLY A  65
ILE A  93
ILE A  13
None
1.05A 3ektB-3in1A:
undetectable
3ektB-3in1A:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k20 OXIDOREDUCTASE

(Corynebacterium
diphtheriae)
PF03358
(FMN_red)
5 ALA A 148
GLY A 145
ILE A 113
ALA A  21
ILE A  20
None
0.92A 3ektB-3k20A:
undetectable
3ektB-3k20A:
17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3keh GLUCOCEREBROSIDASE

(Homo sapiens)
PF02055
(Glyco_hydro_30)
PF17189
(Glyco_hydro_30C)
5 ALA A 232
GLY A 307
ILE A 308
ALA A 301
ILE A 260
None
0.96A 3ektB-3kehA:
undetectable
3ektB-3kehA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lun ULILYSIN

(Methanosarcina
acetivorans)
PF05572
(Peptidase_M43)
5 ALA A 209
ASP A 207
VAL A 175
ILE A  93
ILE A 205
None
0.97A 3ektB-3lunA:
undetectable
3ektB-3lunA:
20.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
None
1.41A 3ektB-3mwsA:
19.8
3ektB-3mwsA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  48
PRO A  81
ILE A  84
None
0.87A 3ektB-3mwsA:
19.8
3ektB-3mwsA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.42A 3ektB-3mwsA:
19.8
3ektB-3mwsA:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3naf CALCIUM-ACTIVATED
POTASSIUM CHANNEL
SUBUNIT
ALPHA-1,CALCIUM-ACTI
VATED POTASSIUM
CHANNEL SUBUNIT
ALPHA-1,CALCIUM-ACTI
VATED POTASSIUM
CHANNEL SUBUNIT
ALPHA-1


(Homo sapiens)
PF03493
(BK_channel_a)
5 ASP A 410
VAL A 414
ILE A 424
ALA A 419
ILE A 416
None
0.98A 3ektB-3nafA:
undetectable
3ektB-3nafA:
9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nio GUANIDINOBUTYRASE

(Pseudomonas
aeruginosa)
PF00491
(Arginase)
5 ASP A  93
VAL A  94
GLY A 127
ALA A 104
ILE A  96
None
0.97A 3ektB-3nioA:
undetectable
3ektB-3nioA:
14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nx3 ACETYLORNITHINE
AMINOTRANSFERASE


(Campylobacter
jejuni)
PF00202
(Aminotran_3)
5 ALA A 109
GLY A 140
ILE A 158
ALA A 129
ILE A 184
None
1.02A 3ektB-3nx3A:
undetectable
3ektB-3nx3A:
12.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pgy SERINE
HYDROXYMETHYLTRANSFE
RASE


(Staphylococcus
aureus)
PF00464
(SHMT)
5 ASP A 316
VAL A 315
GLY A 300
ALA A 293
ILE A 303
None
1.08A 3ektB-3pgyA:
undetectable
3ektB-3pgyA:
13.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ALA A  82
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
SO4  A 101 (-3.5A)
0.63A 3ektB-3t3cA:
18.5
3ektB-3t3cA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t8i PURINE NUCLEOSIDASE,
(IUNH-2)


(Sulfolobus
solfataricus)
PF01156
(IU_nuc_hydro)
6 ASP A 238
ALA A  17
VAL A   6
ILE A 244
ALA A 120
ILE A 121
GOL  A 307 ( 2.6A)
None
None
None
None
CA  A 400 ( 4.8A)
1.36A 3ektB-3t8iA:
undetectable
3ektB-3t8iA:
15.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
1.43A 3ektB-3ttpA:
19.8
3ektB-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.29A 3ektB-3ttpA:
19.8
3ektB-3ttpA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u1h 3-ISOPROPYLMALATE
DEHYDROGENASE


(Bacillus sp.
(in: Bacteria))
PF00180
(Iso_dh)
5 ALA A 291
VAL A  17
GLY A 260
ALA A  73
ILE A  13
None
1.07A 3ektB-3u1hA:
undetectable
3ektB-3u1hA:
13.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.40A 3ektB-3u7sA:
20.1
3ektB-3u7sA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zre THIOL PEROXIDASE

(Yersinia
pseudotuberculosis)
PF08534
(Redoxin)
5 ASP A  57
ALA A  90
GLY A  96
ALA A  62
ILE A  56
None
1.01A 3ektB-3zreA:
undetectable
3ektB-3zreA:
19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zu4 PUTATIVE REDUCTASE
YPO4104/Y4119/YP_401
1


(Yersinia pestis)
PF07055
(Eno-Rase_FAD_bd)
PF12241
(Enoyl_reductase)
PF12242
(Eno-Rase_NADH_b)
5 ASP A  29
GLY A  64
ILE A  37
ALA A  56
ILE A 306
None
1.07A 3ektB-3zu4A:
undetectable
3ektB-3zu4A:
12.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aez WD REPEAT-CONTAINING
PROTEIN SLP1


(Schizosaccharomyces
pombe)
PF00400
(WD40)
PF12894
(ANAPC4_WD40)
5 ALA A 389
ASP A 388
GLY A 367
ALA A 363
ILE A 373
None
1.07A 3ektB-4aezA:
undetectable
3ektB-4aezA:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bma UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE


(Aspergillus
fumigatus)
PF01704
(UDPGP)
5 VAL A 480
GLY A 467
ILE A 468
ALA A 503
ILE A 505
None
1.06A 3ektB-4bmaA:
undetectable
3ektB-4bmaA:
12.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c3y 3-KETOSTEROID
DEHYDROGENASE


(Rhodococcus
erythropolis)
PF00890
(FAD_binding_2)
5 ALA A 180
GLY A 175
ILE A 174
PRO A 134
ILE A 109
None
0.92A 3ektB-4c3yA:
undetectable
3ektB-4c3yA:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e3w ACID PHOSPHATASE

(Francisella
tularensis)
PF00328
(His_Phos_2)
5 ALA A 211
ASP A 207
GLY A 184
ILE A 181
ALA A 159
None
0.84A 3ektB-4e3wA:
undetectable
3ektB-4e3wA:
14.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ess OR187

(synthetic
construct)
PF01661
(Macro)
5 ALA A  18
VAL A  62
GLY A 104
ALA A  96
ILE A  74
None
0.97A 3ektB-4essA:
undetectable
3ektB-4essA:
19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hdj OUTER MEMBRANE
PROTEIN ASSEMBLY
FACTOR BAMB


(Pseudomonas
aeruginosa)
PF13360
(PQQ_2)
5 ASP A 207
GLY A 160
ILE A 159
PRO A 187
ALA A 196
None
0.80A 3ektB-4hdjA:
undetectable
3ektB-4hdjA:
13.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hgv FUMARATE HYDRATASE
CLASS II


(Sinorhizobium
meliloti)
PF00206
(Lyase_1)
PF10415
(FumaraseC_C)
6 ALA A  66
VAL A 144
GLY A  59
ILE A  91
ALA A 124
ILE A  83
None
1.26A 3ektB-4hgvA:
undetectable
3ektB-4hgvA:
11.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hxe PUTATIVE
UNCHARACTERIZED
PROTEIN PH0594


(Pyrococcus
horikoshii)
PF00326
(Peptidase_S9)
PF07676
(PD40)
5 ALA B  61
VAL B  30
ILE B 109
ALA B  28
ILE B  45
None
0.98A 3ektB-4hxeB:
undetectable
3ektB-4hxeB:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j8f HEAT SHOCK 70 KDA
PROTEIN 1A/1B,
HSC70-INTERACTING
PROTEIN


(Homo sapiens;
Rattus
norvegicus)
PF00012
(HSP70)
5 ALA A 157
GLY A 162
ILE A 164
ALA A  70
ILE A  74
None
1.00A 3ektB-4j8fA:
undetectable
3ektB-4j8fA:
13.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jq9 DIHYDROLIPOYL
DEHYDROGENASE


(Escherichia
coli)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ALA A 428
GLY A 411
ILE A 400
ALA A 456
ILE A 438
None
0.89A 3ektB-4jq9A:
undetectable
3ektB-4jq9A:
12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jq9 DIHYDROLIPOYL
DEHYDROGENASE


(Escherichia
coli)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
6 ALA A 428
VAL A 452
GLY A 410
ILE A 409
ALA A 456
ILE A 438
None
1.20A 3ektB-4jq9A:
undetectable
3ektB-4jq9A:
12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lz6 BH2163 PROTEIN

(Bacillus
halodurans)
PF01554
(MatE)
5 ALA A  78
GLY A 386
PRO A 247
ALA A 248
ILE A  75
None
1.08A 3ektB-4lz6A:
undetectable
3ektB-4lz6A:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ng4 PHOSPHOGLYCERATE
KINASE


(Coxiella
burnetii)
PF00162
(PGK)
5 ASP A 293
ASP A 264
VAL A 279
ALA A 277
ILE A 266
MG  A 401 (-2.9A)
None
None
None
None
0.99A 3ektB-4ng4A:
undetectable
3ektB-4ng4A:
14.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-4.3A)
1.24A 3ektB-4njvA:
20.5
3ektB-4njvA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  48
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
0.88A 3ektB-4njvA:
20.5
3ektB-4njvA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.55A 3ektB-4njvA:
20.5
3ektB-4njvA:
86.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p98 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN


(Conexibacter
woesei)
PF02608
(Bmp)
5 ALA A 189
VAL A 157
GLY A 148
ILE A 178
ALA A 217
None
1.07A 3ektB-4p98A:
undetectable
3ektB-4p98A:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pfr TRAP DICARBOXYLATE
TRANSPORTER, DCTP
SUBUNIT


(Rhodobacter
sphaeroides)
PF03480
(DctP)
5 ALA A  84
VAL A  59
GLY A 257
ALA A  57
ILE A  26
None
1.08A 3ektB-4pfrA:
undetectable
3ektB-4pfrA:
14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pyr PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC TRANSPORTER


(Chromobacterium
violaceum)
PF04348
(LppC)
5 VAL A  88
GLY A 107
ILE A 337
ALA A 343
ILE A 146
None
1.09A 3ektB-4pyrA:
undetectable
3ektB-4pyrA:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qnn PHOSPHOLIPASE A 1
FROM HORNET(VESPA
BASALIS) VENOM


(Vespa basalis)
PF00151
(Lipase)
5 ALA A 146
VAL A 109
GLY A 135
ILE A 134
ILE A 113
None
1.04A 3ektB-4qnnA:
undetectable
3ektB-4qnnA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qsl PYRUVATE CARBOXYLASE

(Listeria
monocytogenes)
no annotation 6 ASP H 760
VAL H 759
GLY H 708
ILE H 673
ALA H 721
ILE H 725
None
1.39A 3ektB-4qslH:
undetectable
3ektB-4qslH:
6.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u0g ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 2


(Mycobacterium
tuberculosis)
PF00574
(CLP_protease)
5 ALA A 169
ASP A 175
VAL A 178
GLY A 198
ILE A 179
None
1.06A 3ektB-4u0gA:
undetectable
3ektB-4u0gA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xr9 CALS8

(Micromonospora
echinospora)
PF00984
(UDPG_MGDP_dh)
PF03720
(UDPG_MGDP_dh_C)
PF03721
(UDPG_MGDP_dh_N)
5 ASP A 248
VAL A 249
GLY A 452
ILE A 451
ILE A 250
None
0.98A 3ektB-4xr9A:
undetectable
3ektB-4xr9A:
13.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
5 ASP A  32
ALA A  35
VAL A  39
GLY A  58
ILE A 100
4B1  A 201 (-2.9A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.63A 3ektB-4ydfA:
12.8
3ektB-4ydfA:
32.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yx7 OXYGEN-REGULATED
INVASION PROTEIN
ORGB,ENDOLYSIN


(Escherichia
virus T4;
Salmonella
enterica)
PF00959
(Phage_lysozyme)
5 ALA C 107
ASP C 103
GLY C   1
ALA C 130
ILE C 133
None
1.09A 3ektB-4yx7C:
undetectable
3ektB-4yx7C:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c04 PUTATIVE
PEROXIREDOXIN MT2298


(Mycobacterium
tuberculosis)
PF00578
(AhpC-TSA)
5 ALA A 130
GLY A 105
PRO A   9
ALA A   8
ILE A 127
None
0.95A 3ektB-5c04A:
undetectable
3ektB-5c04A:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cwe CYTOCHROME P450
HYDROXYLASE


(Streptomyces
avermitilis)
PF00067
(p450)
5 ALA A  56
GLY A 340
ILE A 341
ALA A 283
ILE A 307
None
None
None
HEM  A 403 ( 3.7A)
None
1.03A 3ektB-5cweA:
undetectable
3ektB-5cweA:
10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dmh UNCHARACTERIZED
PROTEIN CONSERVED IN
BACTERIA


(Cupriavidus
necator)
PF07005
(DUF1537)
PF17042
(DUF1357_C)
5 ASP A  99
GLY A 233
ILE A 236
ALA A 110
ILE A 106
None
0.78A 3ektB-5dmhA:
undetectable
3ektB-5dmhA:
13.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eg6 RECOMBINING BINDING
PROTEIN SUPPRESSOR
OF HAIRLESS


(Mus musculus)
PF09270
(BTD)
PF09271
(LAG1-DNAbind)
5 VAL C  99
GLY C 130
ILE C 131
PRO C  97
ILE C  76
None
None
BU1  C 521 (-4.7A)
None
None
1.05A 3ektB-5eg6C:
undetectable
3ektB-5eg6C:
12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fq6 SUSC/RAGA FAMILY
TONB-LINKED OUTER
MEMBRANE PROTEIN


(Bacteroides
thetaiotaomicron)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
5 ALA B 769
VAL B 779
GLY B 891
PRO B 857
ILE B 777
None
1.06A 3ektB-5fq6B:
undetectable
3ektB-5fq6B:
6.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iwx 2-C-METHYL-D-ERYTHRI
TOL
2,4-CYCLODIPHOSPHATE
SYNTHASE


(Bacillus
subtilis)
PF02542
(YgbB)
5 VAL A 130
GLY A  23
ILE A  20
ALA A 149
ILE A  99
None
1.08A 3ektB-5iwxA:
undetectable
3ektB-5iwxA:
26.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jfc NADH-DEPENDENT
FERREDOXIN:NADP
OXIDOREDUCTASE
SUBUNIT ALPHA


(Pyrococcus
furiosus)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ALA L 242
ASP L 241
ILE L 182
ALA L 463
ILE L 466
None
1.09A 3ektB-5jfcL:
undetectable
3ektB-5jfcL:
16.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jxk ASP/GLU-SPECIFIC
DIPEPTIDYL-PEPTIDASE


(Porphyromonas
endodontalis)
PF10459
(Peptidase_S46)
5 ALA A 594
VAL A 263
ILE A 689
ALA A 269
ILE A 581
None
1.00A 3ektB-5jxkA:
undetectable
3ektB-5jxkA:
8.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lcw CELL DIVISION CYCLE
PROTEIN 20 HOMOLOG


(Homo sapiens)
PF00400
(WD40)
PF12894
(ANAPC4_WD40)
5 ALA Q 398
ASP Q 397
GLY Q 376
ALA Q 372
ILE Q 382
None
1.09A 3ektB-5lcwQ:
undetectable
3ektB-5lcwQ:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t1p ABC TRANSPORTER,
PERIPLASMIC
SUBSTRATE-BINDING
PROTEIN


(Campylobacter
jejuni)
PF13343
(SBP_bac_6)
5 ALA A 274
GLY A  89
ILE A 260
ALA A 130
ILE A 278
None
1.00A 3ektB-5t1pA:
undetectable
3ektB-5t1pA:
13.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.22A 3ektB-5t2zA:
20.3
3ektB-5t2zA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u25 DIHYDROLIPOAMIDE
DEHYDROGENASE (E3
COMPONENT OF
PYRUVATE AND
2-OXOGLUTARATE
DEHYDROGENASE
COMPLEXES)


(Neisseria
gonorrhoeae)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ALA A 550
GLY A 533
ILE A 522
ALA A 578
ILE A 560
None
0.84A 3ektB-5u25A:
undetectable
3ektB-5u25A:
11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vj7 OXIDOREDUCTASE

(Pyrococcus
furiosus)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ALA A 242
ASP A 241
ILE A 182
ALA A 464
ILE A 467
None
1.04A 3ektB-5vj7A:
undetectable
3ektB-5vj7A:
13.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6d2l HISTONE-ARGININE
METHYLTRANSFERASE
CARM1


(Homo sapiens)
no annotation 5 ALA A 203
VAL A 188
ILE A 197
ALA A 212
ILE A 210
None
None
FTG  A 501 (-4.7A)
None
None
1.05A 3ektB-6d2lA:
undetectable
3ektB-6d2lA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6et5 LIGHT-HARVESTING
PROTEIN B-1015 BETA
CHAIN
LIGHT-HARVESTING
PROTEIN B-1015 GAMMA
CHAIN


(Blastochloris
viridis)
no annotation 5 VAL 1  36
GLY 2  25
ILE 2  29
ALA 1  31
ILE 1  35
BCB  z 101 ( 4.4A)
None
None
None
None
0.97A 3ektB-6et51:
undetectable
3ektB-6et51:
20.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
0.82A 3ektB-6upjA:
18.0
3ektB-6upjA:
47.47